Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasudil and Bevacizumab for Macular Edema in RVO
NCT03391219Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fasudil in macular edema, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Central Macular Thickness at 9 months. Status: unknown.
02
Drugs
fasudil
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT03391219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391219.